Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CRS.L Stock Summary
Top 10 Correlated ETFs
CRS.L
In the News
CRS.L Financial details
Company Rating
Sell
Market Cap
59.29M
Income
-5.58M
Revenue
-2.14M
Book val./share
0.93
Cash/share
0.99
Dividend
-
Dividend %
0%
Employees
-
Optionable
No
Shortable
Yes
Earnings
28 Mar 2024
P/E
15.74
Forward P/E
-
PEG
-0.98
P/S
12.94
P/B
0.85
P/C
77.78
P/FCF
-75.41
Quick Ratio
2.94
Current Ratio
2.94
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.07
EPS next Y
-
EPS next Q
-
EPS this Y
-160.91%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
NAN%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-8.04%
SMA50
-7.04%
SMA100
23.11%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
5%
ROC
0.05%
Gross Margin
100%
Oper. Margin
81%
Profit Margin
82%
Payout
398%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
60.0-110.52
52W High
-30%
52W Low
+28.33%
RSI
42.9
Rel Volume
0.26
Avg Volume
93.79K
Volume
24.23K
Perf Week
1.32%
Perf Month
-9.41%
Perf Quarter
20.31%
Perf Half Y
18.46%
-
-
-
-
Beta
0.772
-
-
Volatility
0.7%, 3.83%
Prev Close
0%
Price
77
Change
-0.72%
CRS.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.11 | -1.39 | 0.41 | 0.12 | -0.06 | |
Net income per share | 0.1 | -1.4 | 0.4 | 0.11 | -0.07 | |
Operating cash flow per share | -0.1 | -0.04 | -0.03 | -0.02 | -0.02 | |
Free cash flow per share | -0.1 | -0.39 | -0.16 | -0.41 | -0.02 | |
Cash per share | 2.51 | 1.01 | 1.47 | 1.45 | 0.99 | |
Book value per share | 2.47 | 1.04 | 1.42 | 1.45 | 0.93 | |
Tangible book value per share | 2.47 | 1.04 | 1.42 | 1.45 | 0.94 | |
Share holders equity per share | 2.47 | 1.04 | 1.42 | 1.45 | 0.93 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 194.35M | 83.93M | 94.01M | 96.36M | 52.02M | |
Enterprise value | 193.42M | 78.01M | 88.57M | 96.31M | 39.76M | |
P/E ratio | 21.07 | -0.64 | 2.72 | 10.97 | -9.33 | |
Price to sales ratio | 18.2 | -0.65 | 2.63 | 9.7 | -10.88 | |
POCF ratio | -19.47 | -25.41 | -39.65 | -46.58 | -32.54 | |
PFCF ratio | -19.47 | -2.28 | -6.95 | -2.84 | -32.54 | |
P/B Ratio | 0.81 | 0.86 | 0.76 | 0.8 | 0.67 | |
PTB ratio | 0.81 | 0.86 | 0.76 | 0.8 | 0.67 | |
EV to sales | 18.12 | -0.6 | 2.48 | 9.69 | -8.32 | |
Enterprise value over EBITDA | 1.95K | 143.67 | -35.51 | 19.94 | -7.13 | |
EV to operating cash flow | -19.38 | -23.62 | -37.35 | -46.56 | -24.88 | |
EV to free cash flow | -19.38 | -2.12 | -6.55 | -2.84 | -24.88 | |
Earnings yield | 0.05 | -1.56 | 0.37 | 0.09 | -0.11 | |
Free cash flow yield | -0.05 | -0.44 | -0.14 | -0.35 | -0.03 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -9.41 | -10.9 | 2.18 | -0.01 | 2.2 | |
Current ratio | 44.46 | 492.47 | 27.93 | 441.47 | 2.94 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | -1.08 | 0.03 | -0.07 | -0.24 | 0.29 | |
Dividend Yield | 0.02 | 0.06 | 0.02 | 0.11 | 0.72 | |
Payout ratio | 0.53 | -0.04 | 0.06 | 1.19 | -6.72 | |
Sales general and administrative to revenue | 0.14 | -0.01 | 0.03 | 0.12 | -0.17 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 10.16 | 4.7 | 15.37 | 0 | |
Capex to revenue | 0 | 0.26 | -0.31 | -3.2 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.3 | 5.72 | 3.57 | 1.85 | 1.19 | |
ROIC | 0.04 | -1.36 | 0.32 | 0.01 | 0 | |
Return on tangible assets | 0.04 | -1.35 | 0.27 | 0.07 | -0.07 | |
Graham Net | 1.22 | 0.56 | 0.71 | 0.72 | 0.52 | |
Working capital | 238.78M | 97.39M | 122.93M | 120.71M | 8.13M | |
Tangible asset value | 238.78M | 97.39M | 122.93M | 120.71M | 78M | |
Net current asset value | 238.78M | 97.39M | 122.93M | 120.71M | 8.13M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 987.64K | 2.27M | 1.49M | 224.37K | 56.76K | |
Average payables | 1.47M | 987.41K | 2.29M | 4.56M | 4.37M | |
Average inventory | -120.68M | -165.22M | -105.55M | -121.48M | -95.43M | |
Days sales outstanding | 66.63 | -7.25 | 4.01 | 2.09 | -4.32 | |
Days payables outstanding | -122.67 | 0 | -408.31 | 523.96 | 0 | |
Days of inventory on hand | 15.1K | 0 | 10.92K | -13.88K | 0 | |
Receivables turnover | 5.48 | -50.33 | 91.07 | 174.43 | -84.53 | |
Payables turnover | -2.98 | 0 | -0.89 | 0.7 | 0 | |
Inventory turnover | 0.02 | 0 | 0.03 | -0.03 | 0 | |
ROE | 0.04 | -1.35 | 0.28 | 0.07 | -0.07 | |
Capex per share | 0 | -0.36 | -0.13 | -0.38 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q4
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.04 | 0.03 | 0.03 | -0.04 | -0.04 | |
Net income per share | 0.06 | 0.03 | 0.03 | -0.06 | -0.06 | |
Operating cash flow per share | -0.01 | -0.01 | -0.01 | 0 | 0 | |
Free cash flow per share | -0.01 | -0.01 | -0.01 | 0 | 0 | |
Cash per share | 1.45 | 1.3 | 1.3 | 0.99 | 0.99 | |
Book value per share | 1.45 | 1.3 | 1.3 | 0.93 | 0.93 | |
Tangible book value per share | 1.45 | 1.3 | 1.3 | 0.93 | 0.94 | |
Share holders equity per share | 1.45 | 1.3 | 1.3 | 0.93 | 0.93 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 96.17M | 91.97M | 81.15M | 70.33M | 52.02M | |
Enterprise value | 96.12M | 91.8M | 80.98M | 58.08M | 39.76M | |
P/E ratio | 4.89 | 11.01 | 9.71 | -3.61 | -2.67 | |
Price to sales ratio | 26.78 | 36.21 | 31.95 | -19.49 | -14.41 | |
POCF ratio | -177.76 | -210.97 | -186.15 | -193.6 | -143.19 | |
PFCF ratio | -177.76 | -210.97 | -186.15 | -193.6 | -143.19 | |
P/B Ratio | 0.8 | 0.85 | 0.75 | 0.91 | 0.67 | |
PTB ratio | 0.8 | 0.85 | 0.75 | 0.91 | 0.67 | |
EV to sales | 26.76 | 36.14 | 31.88 | -16.09 | -11.02 | |
Enterprise value over EBITDA | 47.8 | 4.16K | 3.67K | -67.27 | -46.06 | |
EV to operating cash flow | -177.67 | -210.57 | -185.74 | -159.86 | -109.46 | |
EV to free cash flow | -177.67 | -210.57 | -185.74 | -159.86 | -109.46 | |
Earnings yield | 0.05 | 0.02 | 0.03 | -0.07 | -0.09 | |
Free cash flow yield | -0.01 | 0 | -0.01 | -0.01 | -0.01 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -0.02 | -8.02 | -8.02 | 14.19 | 14.19 | |
Current ratio | 0.38 | 354.55 | 354.55 | 18.23 | 2.94 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | -0.11 | -0.21 | -0.21 | 0.07 | 0.07 | |
Dividend Yield | 0.04 | 0.09 | 0.1 | 0.15 | 0.2 | |
Payout ratio | 0.85 | 3.98 | 3.98 | -2.13 | -2.13 | |
Sales general and administrative to revenue | 0.17 | 0.19 | 0.19 | -0.11 | -0.11 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.39 | 0.86 | 0.86 | 1.11 | 1.11 | |
ROIC | 0.01 | 0.02 | 0.02 | -0.04 | -0.04 | |
Return on tangible assets | 0.04 | 0.02 | 0.02 | -0.06 | -0.06 | |
Graham Net | 0.72 | 0.65 | 0.65 | 0.93 | 0.52 | |
Working capital | -169.71K | 108.24M | 108.24M | 77.68M | 8.13M | |
Tangible asset value | 120.71M | 108.24M | 108.24M | 77.68M | 78M | |
Net current asset value | -169.71K | 108.24M | 108.24M | 77.68M | 8.13M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 28.48K | 67.14K | 77.31K | 38.66K | 28.28K | |
Average payables | 0 | 153.07K | 306.15K | 2.24M | 4.18M | |
Average inventory | -60.47M | -114.61M | -108.29M | -54.15M | -34.97M | |
Days sales outstanding | 1.43 | 2.74 | 2.74 | 0 | -1.41 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 63.05 | 32.86 | 32.86 | 0 | -63.82 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.04 | 0.02 | 0.02 | -0.06 | -0.06 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CRS.L Frequently Asked Questions
What is Crystal Amber Fund Limited stock symbol ?
Crystal Amber Fund Limited is a GB stock and trading under the symbol CRS.L
What is Crystal Amber Fund Limited stock quote today ?
Crystal Amber Fund Limited stock price is $77 today.
Is Crystal Amber Fund Limited stock public?
Yes, Crystal Amber Fund Limited is a publicly traded company.